Latest News: Sales & Marketing
Discover the latest tips, news and insights from Zephyr Health
Zephyr Health is passionate about turning data into meaningful insights. At the Veeva Summit in Philly, we helped bring the Life Sciences into the #insightsgeneration – and had a great time while doing it!
In this episode of the SaaS Breakthrough podcast with host David Abrams, Zephyr Health’s Leilani Latimer talks about the pain points within the Life Sciences industry, and other strategies for marketing success.
As we head toward 2018, global marketing leaders are sharing their focus for the new year, and the hottest trends that will be driving marketing teams. Hear from Zephyr Health’s VP of Global Marketing in our 2018 Marketing Manifesto!
Life sciences companies rely on a variety of solutions to incorporate market access data and insights – but they are not finding those solutions sufficient (or efficient!). Here are three ways holistic big data solutions can bridge market access gaps between teams.
At Medforce 2017, Zephyr Health CEO Lance Scott moderated a panel with Abbott’s Megan Oh and Medtronic’s Nathan Phillipp on the power of data and insights. Read our recap to find out their best practices for implementing a big data strategy.
John Jaeger, Partner and US Pricing and Market Access Practice Lead, Decision Resources Group, discusses market access challenges in pharma, and how top Life Sciences executives can overcome these hurdles and achieve success.
Zephyr Health and DRG announce the release of Provider Market Access; the first of its kind, Provider Market Access operationalizes formulary status for commercial teams for improved account planning, physician engagement and sales effectiveness.
The healthcare industry continues to shift its focus toward the importance of outcomes, leaving sales teams to take a back seat. Here’s how aligning with Market Access can put them back in the driver’s seat and steer them toward success.
Commercial teams who can act on market access insights in near real-time have a competitive edge and deeper relationships with healthcare professionals. Yet this critical information does not always make it to the prescriber-facing teams in a timely fashion.
Over 500 leaders from life sciences companies met at the eyeforpharma 2017 commercial conference. They discussed innovation, integration, and collaboration – and data and insights were the focus of many of these conversations.
To better understand the future of market access within life sciences companies, especially the changing dynamics between market access and brand strategy, we’ve put together a short survey. We’d love to hear what you think!
With changes in the healthcare industry, a successful modern sales conversation must now include not just the treatment, but the entire care ecosystem, from the safety of the treatment, to real-world evidence, and a broad view of the patient pathway.